This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MSON Misonix (MSON) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Misonix Stock (NASDAQ:MSON) 30 days 90 days 365 days Advanced Chart Get Misonix alerts:Sign Up Key Stats Today's Range$26.54▼$26.5450-Day Range$24.89▼$26.5452-Week Range$11.04▼$26.99Volume2 shsAverage Volume60,302 shsMarket Capitalization$462.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY. Read More Receive MSON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter. Email Address MSON Stock News HeadlinesSoutheast Fort Worth community drives ‘miracle' Masonic orphanage redevelopmentJuly 17, 2025 | msn.comWhat style will Ryan Mason's West Brom play this season?July 15, 2025 | msn.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 2 at 2:00 AM | Brownstone Research (Ad)How Ryan Mason's West Brom vision is already shaping upJuly 13, 2025 | msn.comNagpur Freemasons hold historic Lodge Meeting at Umling La, world’s highest motorable roadJuly 13, 2025 | msn.comThe Devon pub that went from zero to Michelin star in six monthsJuly 12, 2025 | msn.com'Fascinating access to Mason's session'July 10, 2025 | msn.comMississippi State baseball, Brian O'Connor land George Mason's Andrew Raymond in transfer portalJuly 10, 2025 | msn.comSee More Headlines MSON Stock Analysis - Frequently Asked Questions How were Misonix's earnings last quarter? Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.24) by $0.02. The medical equipment provider earned $19.69 million during the quarter. Misonix had a negative net margin of 19.55% and a negative trailing twelve-month return on equity of 10.36%. What other stocks do shareholders of Misonix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Misonix investors own include EDAP TMS (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Fulgent Genetics (FLGT), Ampio Pharmaceuticals (AMPE), Sociedad Quimica y Minera (SQM) and Sorrento Therapeutics (SRNE). Company Calendar Last Earnings9/02/2021Today8/02/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Laboratory Apparatus & Furniture Sub-IndustryN/A Current SymbolNASDAQ:MSON CIK880432 Webwww.misonix.com Phone(631) 694-9555Fax631-694-9412Employees254Year Founded1959Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.47 million Net Margins-19.55% Pretax Margin-19.37% Return on Equity-10.36% Return on Assets-7.29% Debt Debt-to-Equity Ratio0.29 Current Ratio2.61 Quick Ratio1.92 Sales & Book Value Annual Sales$74.02 million Price / Sales6.24 Cash FlowN/A Price / Cash FlowN/A Book Value$7.77 per share Price / Book3.42Miscellaneous Outstanding Shares17,410,000Free Float11,893,000Market Cap$462.06 million OptionableNot Optionable Beta1.36 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:MSON) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Misonix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Misonix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.